Provectus’s Substack

Home
Archive
About
Intralesional Path to Cancer Drug Approval
Fill Factor: the ratio of PV-10 volume to tumor volume to deliver a constant dose of rose bengal sodium per quantity of tumor
 • 
Provectus Biopharmaceuticals
News Day: April 21, 2024
PV-10-injectable head and neck cancers; Orally administered anticancer rose bengal drug formulation; Ophthalmology & rose bengal photodynamic…
 • 
Provectus Biopharmaceuticals
Stage IV Melanoma: “…the company that saved my life”
A patient testimonial about his investigational cancer immunotherapy PV-10 experience
 • 
Provectus Biopharmaceuticals
Most Popular
View all
Building Trust: Bascom Palmer Eye Institute, Provectus Biopharmaceuticals, and RBS PDAT
 • Provectus Biopharmaceuticals
Cancer immunotherapy PV-10’s evolution into a cancer immunotherapy
 • Provectus Biopharmaceuticals
Provectus’s Rose Bengal Sodium: A “Proprietary” Molecule and Proprietary Drug Substance
 • Provectus Biopharmaceuticals
Provectus Full-Thickness Cutaneous Wound Healing Poster Presentation at 2024 Society for Investigative Dermatology Annual Meeting
 • Provectus Biopharmaceuticals
Cancer Immunotherapy PV-10's Innate Immune Signaling
 • Provectus Biopharmaceuticals
News Day: April 21, 2024
 • Provectus Biopharmaceuticals
Ophthalmology Deal Structure
A to-be-formed Provectus spin-out would advance the combination therapy of Bascom Palmer's light source (device) and a formulation of Provectus’s…
 • 
Provectus Biopharmaceuticals
Building Trust: Bascom Palmer Eye Institute, Provectus Biopharmaceuticals, and RBS PDAT
Rose Bengal Sodium Photodynamic Antimicrobial Therapy for Eye Infections
 • 
Provectus Biopharmaceuticals
More Provectus Intellectual Property
Company announces U.S. patent allowances & awards in virology, pediatric solid tumor cancers, and vaccines
 • 
Provectus Biopharmaceuticals
Provectus Head and Neck Cancer Poster Presentation at 2024 American Association for Cancer Research Annual Meeting
AACR poster title: “PV 10 induces endoplasmic reticulum stress and autophagy, triggering immunogenic cell death and anti-tumor immunity in head and neck…
 • 
Provectus Biopharmaceuticals
Provectus Full-Thickness Cutaneous Wound Healing Poster Presentation at 2024 Society for Investigative Dermatology Annual Meeting
SID Poster title: "Assessing the safety and toxicity of multi-dosed topical Rose Bengal Sodium (RBS) in a murine model of full-thickness cutaneous…
 • 
Provectus Biopharmaceuticals
Provectus Provides Updated PV-10 Overall Survival Data on Hepatic Metastatic Uveal Melanoma
Provectus last provided an update on PV-10 data for its uveal melanoma (UM) metastatic to the liver (mUM) clinical trial in Provectus’s November 2023…
 • 
Provectus Biopharmaceuticals
Audio Recording of Provectus's First Quarter 2024 Conference Call
Provectus held its first quarter 2024 conference call on Thursday, February 22nd. The audio recording of the call is below. One hundred and thirty four…
 • 
Provectus Biopharmaceuticals
Provectus’s Substack
Provectus’s Substack
My personal Substack

Provectus’s Substack

AboutArchiveSitemap
© 2024 Provectus Biopharmaceuticals
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture